Compare Amgen, Inc. (AMGN) vs Alphabet Inc Class A (GOOGL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amgen, Inc. vs Alphabet Inc Class A — how do they compare? Amgen, Inc. trades at $363.55 (market cap $196.12B), while Alphabet Inc Class A trades at $356.06 (market cap $4.35T). The key difference: Alphabet Inc Class A is far larger — about 22.2× Amgen, Inc.'s market cap, and Amgen, Inc. pays the higher dividend (2.77%). Which is the better fit depends on your goals.
| AMGN | GOOGL | |
|---|---|---|
Market Cap | $196.12B | $4.35T |
Sector | Health | Media |
52-Week High | $388.16 | $402.62 |
52-Week Low | $271.18 | $180.19 |
Enterprise Value | $241.41B | $4.31T |
Dividend Yield | 2.77% | 0.25% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.
The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.
Alphabet (GOOGL) trades at $357.18, down 0.48% on the day, with a neutral technical signal but strong fundamental performance. The company reported robust Q1 2026 earnings of $5.11 EPS, significantly beating expectations of $2.64, continuing a trend of earnings outperformance. Revenue growth accelerated to $402.84 billion in 2025 with net income margins expanding to 32.8%. Analyst consensus remains overwhelmingly bullish with 85% buy ratings and a $432.22 price target representing 21% upside potential.
Alphabet presents a compelling investment case driven by AI leadership, consistent earnings beats, and strong cash flow generation. Key risks include regulatory scrutiny, competitive pressures in search and cloud, and market volatility. The company's $7.24 billion net cash flow in 2025 and improving profitability metrics support continued growth, while recent YouTube price increases and AI infrastructure partnerships provide additional revenue catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About Alphabet Inc Class A
Alphabet, the parent company of Google, earns nearly 90% of its revenue from Google services, mainly through advertising. Other revenue comes from subscriptions (YouTube TV, YouTube Music), platform sales (Play Store purchases), and devices (Pixel, Chromebooks, Chromecast). Google Cloud contributes around 10%, while investments in self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) make up the rest.
Read more on GOOGL →
